RadLogics
RadLogics is a privately held US healthcare-AI company that applies its patented OmniPoint AI Platform to archived CT, MRI, and PET scans and EHR data to surface previously unidentified cancer findings, selling on a subscription basis to cancer centers via direct enterprise sales.
- Company typePrivate
- Founded2010
- HeadquartersMilpitas, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What RadLogics does
RadLogics is a privately held US medical-imaging analytics company founded in 2010 that operates the patented OmniPoint AI Platform to analyze archived CT, MRI, and PET scans alongside structured and unstructured electronic health record data. Its core function is to surface previously unidentified cancer findings in imaging archives and to flag patients at elevated cancer risk for oncologist review, using a four-stage workflow of PACS/EHR data ingestion, AI analysis, clinical validation, and patient outreach. The platform is differentiated by its retrospective "missed-finding" positioning and by a proprietary sequential AI risk-scoring methodology for malignancy prediction in indeterminate lung nodules, supported by granted US and Japan patents and peer-reviewed clinical publications.
The company sells to a single primary vertical — cancer centers and hospital oncology departments — via direct enterprise sales, integrating its platform with customers' existing PACS and EHR systems and pricing on a quote-based, recurring subscription basis. No public pricing tiers, customer logos, or revenue figures are disclosed. RadLogics is governed by New York law, is led by four co-founders (Moshe Becker as Chairman, Hayit Greenspan PhD as Chief Scientist, Lev Ayzenberg as CTO, and James Gallagher as CFO) plus a co-founder Chief Medical Officer, and has raised approximately $2.85M across two disclosed funding rounds (2011 seed and 2014 round led by Omninet Capital and Winnovation).
The business is small — 11–50 employees — with no disclosed institutional investors beyond the 2014 round and no subsequent funding events in the input data. Geographic scope is stated as the United States only, and the company's marketing centers on enterprise demo requests, clinical publications, and B2B channels such as LinkedIn and YouTube rather than broad distribution partnerships.
RadLogics firmographics
Firmographics- Name
- RadLogics
- Legal name
- RADLogics
- Website
- https://radlogics.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- RadLogics is a privately held US healthcare-AI company that applies its patented OmniPoint AI Platform to archived CT, MRI, and PET scans and EHR data to surface previously unidentified cancer findings, selling on a subscription basis to cancer centers via direct enterprise sales.
- Ownership category
- akta.pro rank
RadLogics industry classification
Industry- Product category
- Medical Imaging AI / Oncology Software
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Sleep & Airway Orthodontics (OSA Appliances/Expansion) (HLABABAI)
- akta.pro secondary industry
- Real-World Data (RWD) Platforms & Clinical Data Curation (HLACAIAJ)
Keywords
Where RadLogics is headquartered
LocationHeadquarters
- HQ city
- Milpitas
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
RadLogics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- AI-Powered Cancer Detection Platform: RADLogics provides AI analysis services to cancer centers, connecting to their PACS and EHR systems to analyze archived imaging and medical records. The company generates revenue by helping cancer centers surface unidentified cancers, which drives new patient encounters and measurable revenue for the centers while mitigating risk and liability exposure.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
RadLogics product offering
Product offeringCore offering
RadLogics provides the OmniPoint™ AI platform, which connects to cancer centers' PACS and EHR systems to analyze archived CT, MRI, and PET scans along with structured and unstructured medical records data. The platform flags previously unidentified cancer findings that meet clinical significance thresholds and routes them to oncologists for clinical review, after which patient outreach workflows are triggered.
Product overview
RADLogics offers a single unified product platform called OmniPoint™ AI, which provides end-to-end AI-powered cancer discovery. The platform combines AI image analysis (applying advanced algorithms to CT, MRI, and PET scans) and medical records analysis (processing structured and unstructured EHR data) within a four-stage workflow: Data Ingestion (connecting to PACS and EHR systems), AI Analysis (flagging clinically significant findings), Clinical Review (routing to oncologists for validation), and Patient Outreach (connecting at-risk patients with care).
Differentiator
Problem solved
Functional benefit
Products and services
- OmniPoint™ AI Platform Patented AI platform that connects to existing PACS and EHR systems to analyze archived CT, MRI, and PET imaging alongside structured and unstructured medical records. It flags cancer findings meeting clinical significance thresholds and routes them to oncologists for clinical validation before triggering patient outreach workflows. Built for hospitals with oncology departments and dedicated cancer centers.
Quantifiable outcome
- Published clinical evidence through peer-reviewed publications including evaluation of sequential AI risk scoring for malignancy prediction in indeterminate lung nodules
Companies that use RadLogics
Customer profileSegments1 record
Ideal customer profiles1 record
RadLogics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature2 records
RadLogics partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights4 records
RadLogics competitors and assessment
Company assessmentBroad incumbents
- iCAD: iCAD provides AI-based cancer detection and radiation therapy solutions across mammography, CT, and X-ray. It is a broader incumbent in oncology imaging AI with a wider product portfolio than RADLogics' focused offering.
- Google Health (Google DeepMind): Google Health and DeepMind produce foundational AI models for medical imaging, including mammography and radiology. It is a broad incumbent whose general-purpose imaging AI could compress the differentiated space RADLogics occupies.
- IBM Watson Health (Merative): IBM Watson Health (now Merative) offers enterprise imaging AI and clinical decision support tools across radiology and oncology. Its scale and enterprise distribution make it a broad competitive force in healthcare AI imaging.
Direct peers
- Aidoc: Aidoc provides AI-driven medical imaging analysis for CT and other modalities, integrated with PACS and EHR workflows. It is a direct competitor in AI radiology analytics and shares RADLogics' enterprise go-to-market with hospitals and healthcare systems.
- DeepHealth (a RadNet company): DeepHealth builds AI tools for radiology workflow, image analysis, and cancer screening across modalities. Its focus on oncology screening and retrospective analysis directly parallels RADLogics' archived-data cancer detection value proposition.
- Arterys: Arterys delivers AI-powered medical imaging analytics with cloud-based PACS integration and AI marketplaces for radiology, aligning closely with RADLogics' approach of integrating AI into imaging workflows for clinical decision support.
- Riverain Technologies: Riverain Technologies applies AI to chest imaging (CT and X-ray) to improve lung nodule detection and oncology workflow — directly overlapping with RADLogics' lung nodule malignancy risk scoring capabilities.
- Viz.ai: Viz.ai offers AI-powered imaging analysis that flags suspected findings and routes them to specialists for clinical review — closely paralleling RADLogics' flagged-finding → oncologist → patient outreach workflow, particularly in time-sensitive disease areas.
- Zebra Medical Vision: Zebra Medical Vision (now part of Nanox) develops AI algorithms for analyzing CT, MRI, and other imaging modalities to surface findings at scale. It competes directly with RADLogics in retrospective and population-level image analytics.
Emerging players
- Tempus Labs: Tempus combines molecular and clinical data with AI for precision oncology. While its core is molecular profiling, its data-platform approach to oncology decision support makes it a thematic emerging peer to RADLogics' data-driven cancer discovery model.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
RadLogics social profiles
Digital presenceRadLogics financial estimates
Financial estimateRevenue estimate
Valuation estimate
RadLogics leadership team
Management profileNumber of profiles
Profiles5 records
RadLogics funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RadLogics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RadLogics
What does RadLogics do?
RadLogics provides the OmniPoint™ AI platform, which connects to cancer centers' PACS and EHR systems to analyze archived CT, MRI, and PET scans along with structured and unstructured medical records data. The platform flags previously unidentified cancer findings that meet clinical significance thresholds and routes them to oncologists for clinical review, after which patient outreach workflows are triggered.
Is RadLogics a public or private company?
RadLogics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was RadLogics founded?
RadLogics was founded in 2010. It employs 11 to 50 people.
Where is RadLogics based?
RadLogics is headquartered in Milpitas, United States, in the North America region.
How does RadLogics make money?
One revenue line is on record: AI-Powered Cancer Detection Platform.
Who are RadLogics's main competitors?
Broad incumbents on record are iCAD, Google Health (Google DeepMind) and IBM Watson Health (Merative). Direct peers are Aidoc, DeepHealth (a RadNet company), Arterys, Riverain Technologies, Viz.ai and Zebra Medical Vision. Tempus Labs is listed as an emerging player.
Does RadLogics have an API?
No public API is recorded for RadLogics.
What industry is RadLogics in?
RadLogics's product category is Medical Imaging AI / Oncology Software. Its primary akta.pro industry code is HLABABAI, Sleep & Airway Orthodontics (OSA Appliances/Expansion), with a secondary code of HLACAIAJ, Real-World Data (RWD) Platforms & Clinical Data Curation. Its NAICS code is 62151 and its SIC code is 8090.